Step by Stepa HemeOncBuddy patient portal

Dacarbazine

Illustration: Dacarbazine

Say it: da-KAR-buh-zeen

Dacarbazine is a chemotherapy medicine that damages the DNA in cancer cells so they cannot grow.

What it is

Your liver changes dacarbazine into its active form. It then adds small chemical pieces to DNA and damages it. Cancer cells cannot copy themselves and die.

Often used for

How you get it

Dacarbazine is given through a vein (IV), often over 30 to 60 minutes. For Hodgkin lymphoma it is often given every 2 weeks with other medicines. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Dacarbazine?
Dacarbazine is a chemotherapy medicine that damages the DNA in cancer cells so they cannot grow.
What is Dacarbazine used for?
Hodgkin lymphoma (as part of a combination); melanoma that has spread; and some other cancers, such as sarcomas.
How is Dacarbazine given?
Dacarbazine is given through a vein (IV), often over 30 to 60 minutes. For Hodgkin lymphoma it is often given every 2 weeks with other medicines. Your schedule may be different.
What are the common side effects of Dacarbazine?
Nausea and vomiting, which can be strong. Low blood counts, which raise your risk of infection and bleeding. Flu-like feelings, such as fever, muscle aches, and tiredness. Poor appetite. Burning or pain in the vein during the infusion. Hair thinning. Skin that burns easily in the sun.
When should I call my care team while taking Dacarbazine?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Pain, swelling, or redness where the IV went in; Yellow skin or eyes, belly pain, or belly swelling; Bleeding or bruising that will not stop, black or bloody stools, or blood in your urine; Trouble breathing, swelling of the face or throat, or a racing heart.
Which chemotherapy plans include Dacarbazine?
AAVD, ABVD.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.